Pages with the fewest revisions

Jump to navigation Jump to search

Showing below up to 250 results in range #1 to #250.

View (previous 250 | next 250) (20 | 50 | 100 | 250 | 500)

  1. Enterogenous cyst‏‎ (1 revision)
  2. Glands‏‎ (1 revision)
  3. Formalin-fixed paraffin-embedded‏‎ (1 revision)
  4. Cytotoxic T-lymphocyte-associate antigen 4‏‎ (1 revision)
  5. Dragon NaturallySpeaking‏‎ (1 revision)
  6. Tattoo‏‎ (1 revision)
  7. Sequestrum‏‎ (1 revision)
  8. Mixed papilloma‏‎ (1 revision)
  9. Prevalence‏‎ (1 revision)
  10. Syndrome‏‎ (1 revision)
  11. CAP Molecular Diagnosis of AML‏‎ (1 revision)
  12. CCC‏‎ (1 revision)
  13. Positron emission tomography‏‎ (1 revision)
  14. Xanthogranuloma‏‎ (1 revision)
  15. Adrenoleukodystrophy‏‎ (1 revision)
  16. Site‏‎ (1 revision)
  17. Prognosis‏‎ (1 revision)
  18. Hyperthyroidism‏‎ (1 revision)
  19. Extranodal extension‏‎ (1 revision)
  20. Prostatitis‏‎ (1 revision)
  21. Ewing-like tumours‏‎ (1 revision)
  22. Mole‏‎ (1 revision)
  23. Chromosomal polymorphisms‏‎ (1 revision)
  24. Case:Notes/IHC‏‎ (1 revision)
  25. GBM‏‎ (1 revision)
  26. Pituicytoma‏‎ (1 revision)
  27. CD23‏‎ (1 revision)
  28. Case 100‏‎ (1 revision)
  29. Maxilla‏‎ (1 revision)
  30. Left colon‏‎ (1 revision)
  31. Serous cystadenoma‏‎ (1 revision)
  32. Smooth muscle tumours‏‎ (1 revision)
  33. Post-graduate year‏‎ (1 revision)
  34. Secretory carcinoma‏‎ (1 revision)
  35. Adrenal gland cysts‏‎ (1 revision)
  36. Angiogenesis‏‎ (1 revision)
  37. Case 119‏‎ (1 revision)
  38. Molecular neuropathology‏‎ (1 revision)
  39. LSC‏‎ (1 revision)
  40. Dermolipectomy‏‎ (1 revision)
  41. Fellow‏‎ (1 revision)
  42. Transportation related Deaths‏‎ (1 revision)
  43. Nodular glomerulosclerosis‏‎ (1 revision)
  44. IPFitis‏‎ (1 revision)
  45. Tissue microarray‏‎ (1 revision)
  46. Case 39‏‎ (1 revision)
  47. Anaplastic carcinoma‏‎ (1 revision)
  48. Sinus invasion‏‎ (1 revision)
  49. Esophageal carcinoma‏‎ (1 revision)
  50. LEOPARD syndrome‏‎ (1 revision)
  51. Incidentaloma‏‎ (1 revision)
  52. Quiz:L4E uropathology (2018)‏‎ (1 revision)
  53. Acute pneumonia‏‎ (1 revision)
  54. Case 118‏‎ (1 revision)
  55. PEA‏‎ (1 revision)
  56. Oligohydramnios‏‎ (1 revision)
  57. Papillary carcinoma of the breast‏‎ (1 revision)
  58. Polar Spongioblastoma‏‎ (1 revision)
  59. Slide assessment checklist‏‎ (1 revision)
  60. Ampulla‏‎ (1 revision)
  61. Bowel obstruction‏‎ (1 revision)
  62. Medullomyoblastoma‏‎ (1 revision)
  63. Prolapse‏‎ (1 revision)
  64. Gastric snakeskin appearance‏‎ (1 revision)
  65. An introduction to endocrine pathology‏‎ (1 revision)
  66. Renal epithelial and stromal tumour‏‎ (1 revision)
  67. Primary lymphoid organs‏‎ (1 revision)
  68. Rheumatology‏‎ (1 revision)
  69. Cytokeratin 34 beta E12‏‎ (1 revision)
  70. Bortezomib‏‎ (1 revision)
  71. Avascular necrosis‏‎ (1 revision)
  72. Quiz:L4E dermatopathology (2018)‏‎ (1 revision)
  73. Gastrointestinal bleeding‏‎ (1 revision)
  74. Hidradenoma‏‎ (1 revision)
  75. Gilbert syndrome‏‎ (1 revision)
  76. Ganglion‏‎ (1 revision)
  77. OP:Motto‏‎ (1 revision)
  78. Plasmacytosis mucosae‏‎ (1 revision)
  79. Pyrosequencing‏‎ (1 revision)
  80. CAP Molecular Diagnosis of Lung Cancer‏‎ (1 revision)
  81. Quiz:L4E rule 4 (2018)‏‎ (1 revision)
  82. ERG‏‎ (1 revision)
  83. Case 80‏‎ (1 revision)
  84. Corneal button‏‎ (1 revision)
  85. Adenomyosis‏‎ (1 revision)
  86. Knee replacement specimen grossing‏‎ (1 revision)
  87. Acromegaly‏‎ (1 revision)
  88. Molecular Genetic Diagnosis‏‎ (1 revision)
  89. Sinonasal teratocarcinosarcoma‏‎ (1 revision)
  90. Atrophic carcinoma‏‎ (1 revision)
  91. Urology links‏‎ (1 revision)
  92. Steatoma‏‎ (1 revision)
  93. Micropapillary breast carcinoma‏‎ (1 revision)
  94. CAP Breast Cancer and Molecular‏‎ (1 revision)
  95. Fibroma‏‎ (1 revision)
  96. GA‏‎ (1 revision)
  97. LM‏‎ (1 revision)
  98. HMB-45‏‎ (1 revision)
  99. Luteinized follicular cyst‏‎ (1 revision)
  100. Larynx‏‎ (1 revision)
  101. Lung carcinoma‏‎ (1 revision)
  102. Duodenitis‏‎ (1 revision)
  103. Eosinophilic granuloma‏‎ (1 revision)
  104. Ion AmpliSeq Cancer Hotspot Panel v2‏‎ (1 revision)
  105. H3F3A‏‎ (1 revision)
  106. Ankylosing spondylitis‏‎ (1 revision)
  107. CD3‏‎ (1 revision)
  108. Environmental causes of death‏‎ (1 revision)
  109. GFAP‏‎ (1 revision)
  110. Grossing notes‏‎ (1 revision)
  111. Treatment‏‎ (1 revision)
  112. Iron deficiency anemia‏‎ (1 revision)
  113. HELLP syndrome‏‎ (2 revisions)
  114. Hypoxic-ischemic encephalopathy‏‎ (2 revisions)
  115. Quiz:L4E gastrointestinal pathology (2018)‏‎ (2 revisions)
  116. Steroidogenic factor 1‏‎ (2 revisions)
  117. PAC‏‎ (2 revisions)
  118. Supraclavicular artery island flap‏‎ (2 revisions)
  119. STAT6‏‎ (2 revisions)
  120. Rheumatic heart disease‏‎ (2 revisions)
  121. Rhabdoid tumour‏‎ (2 revisions)
  122. Labial salivary gland‏‎ (2 revisions)
  123. Plume of froth‏‎ (2 revisions)
  124. Anaplastic ologodendroglioma‏‎ (2 revisions)
  125. Lead toxicity‏‎ (2 revisions)
  126. MAC‏‎ (2 revisions)
  127. Madelung's disease‏‎ (2 revisions)
  128. Fistula for hemodialysis‏‎ (2 revisions)
  129. Hematopoietic stem cell transplantation‏‎ (2 revisions)
  130. Clinical medicine‏‎ (2 revisions)
  131. Online Computer Library Center‏‎ (2 revisions)
  132. Tularemia‏‎ (2 revisions)
  133. Shoulder dislocation‏‎ (2 revisions)
  134. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy‏‎ (2 revisions)
  135. Leukoedema‏‎ (2 revisions)
  136. Hard palate‏‎ (2 revisions)
  137. Diabetes‏‎ (2 revisions)
  138. SOX11‏‎ (2 revisions)
  139. NordiQC‏‎ (2 revisions)
  140. Epstein-Barr Virus-associated gastric carcinoma‏‎ (2 revisions)
  141. Transanal minimally invasive surgery‏‎ (2 revisions)
  142. Health Sciences Centre‏‎ (2 revisions)
  143. Case 91‏‎ (2 revisions)
  144. Paired box gene 5‏‎ (2 revisions)
  145. Pacinian corpuscles‏‎ (2 revisions)
  146. Myocardial injury after non-cardiac surgery‏‎ (2 revisions)
  147. Radical hysterectomy for cervical cancer grossing‏‎ (2 revisions)
  148. Cryptogenic cirrhosis‏‎ (2 revisions)
  149. Esophageal dysplasia‏‎ (2 revisions)
  150. Case 114‏‎ (2 revisions)
  151. Sectioning and extensively examining of the fimbriated end‏‎ (2 revisions)
  152. Immunofluorescence‏‎ (2 revisions)
  153. Cutaneous lymphoma‏‎ (2 revisions)
  154. Skin ellipse‏‎ (2 revisions)
  155. Cholecystitis‏‎ (2 revisions)
  156. Apparent diffusion coefficient‏‎ (2 revisions)
  157. Quiz:L4E rules 1-3 (2018)‏‎ (2 revisions)
  158. CCS‏‎ (2 revisions)
  159. Not otherwise specified‏‎ (2 revisions)
  160. Dagger‏‎ (2 revisions)
  161. Atypical adenomatous hyperplasia‏‎ (2 revisions)
  162. Collagen vascular diseases‏‎ (2 revisions)
  163. Cirrhosis‏‎ (2 revisions)
  164. Carcinoid tumour‏‎ (2 revisions)
  165. Bowel-associated dermatosis-arthritis syndrome‏‎ (2 revisions)
  166. Carney triad‏‎ (2 revisions)
  167. AKA‏‎ (2 revisions)
  168. Neoadjuvant therapy‏‎ (2 revisions)
  169. Germ layers‏‎ (2 revisions)
  170. Mucinous cystadenoma‏‎ (2 revisions)
  171. Spinal mass‏‎ (2 revisions)
  172. Acute disseminated encephalomyelitis‏‎ (2 revisions)
  173. Polyomavirus‏‎ (2 revisions)
  174. Glucagonoma‏‎ (2 revisions)
  175. Lymphoma protocol‏‎ (2 revisions)
  176. GCT‏‎ (2 revisions)
  177. Invasive ductal carcinoma‏‎ (2 revisions)
  178. Case 92‏‎ (2 revisions)
  179. Hepatitis‏‎ (2 revisions)
  180. Tumours with ovarian stroma‏‎ (2 revisions)
  181. Autoimmune enteropathy‏‎ (2 revisions)
  182. Prostate carcinoma with amphicrine features‏‎ (2 revisions)
  183. Case 104‏‎ (2 revisions)
  184. Pneumatosis cystoides intestinalis‏‎ (2 revisions)
  185. Case 40‏‎ (2 revisions)
  186. PubMed Identifier‏‎ (2 revisions)
  187. Everolimus‏‎ (2 revisions)
  188. Cystectomy‏‎ (2 revisions)
  189. Transitional cell carcinoma‏‎ (2 revisions)
  190. Polyps‏‎ (2 revisions)
  191. Nodular hyperplasia‏‎ (2 revisions)
  192. Case 109‏‎ (2 revisions)
  193. List of Microdeletion Syndromes‏‎ (2 revisions)
  194. RP‏‎ (2 revisions)
  195. LCA‏‎ (2 revisions)
  196. Laboratory information system‏‎ (2 revisions)
  197. Indeterminate margin‏‎ (2 revisions)
  198. Endocarditis‏‎ (2 revisions)
  199. Intimal sarcoma‏‎ (2 revisions)
  200. Esophageal cancer‏‎ (2 revisions)
  201. Bazex syndrome‏‎ (2 revisions)
  202. Rezum‏‎ (2 revisions)
  203. Pemphigoid‏‎ (2 revisions)
  204. Thrombomodulin‏‎ (2 revisions)
  205. Case 83‏‎ (2 revisions)
  206. CD5‏‎ (2 revisions)
  207. Pseudoseizures‏‎ (2 revisions)
  208. Autosomal recessive polycystic kidney disease‏‎ (2 revisions)
  209. Central neurocytoma‏‎ (2 revisions)
  210. Colonic leiomyoma‏‎ (2 revisions)
  211. Poorly differentiated thyroid carcinoma‏‎ (2 revisions)
  212. Hydatid of Morgagni‏‎ (2 revisions)
  213. Endometrium with psammoma bodies‏‎ (2 revisions)
  214. Endoscopic mucosal resection‏‎ (2 revisions)
  215. Inverted papilloma‏‎ (2 revisions)
  216. Gastric heterotopia‏‎ (2 revisions)
  217. Fat embolism‏‎ (2 revisions)
  218. Columnar epithelial dysplasia‏‎ (2 revisions)
  219. Intramucosal carcinoma‏‎ (2 revisions)
  220. Respiratory bronchiolitis-interstitial lung disease‏‎ (2 revisions)
  221. Formula‏‎ (2 revisions)
  222. Case 43‏‎ (2 revisions)
  223. Lobular breast carcinoma‏‎ (2 revisions)
  224. Invasive ductal carinoma‏‎ (2 revisions)
  225. Pathergy‏‎ (2 revisions)
  226. STUMP‏‎ (2 revisions)
  227. Antiphospholipid antibody syndrome‏‎ (2 revisions)
  228. PowerChart‏‎ (2 revisions)
  229. Section sign‏‎ (2 revisions)
  230. Signs‏‎ (2 revisions)
  231. Fetus papyraceus‏‎ (2 revisions)
  232. Large bowel‏‎ (2 revisions)
  233. Microglandular adenosis‏‎ (2 revisions)
  234. Missed colorectal biopsy‏‎ (2 revisions)
  235. Serrated adenoma‏‎ (2 revisions)
  236. Medullary carcinoma‏‎ (2 revisions)
  237. Malignant rhabdoid tumour‏‎ (2 revisions)
  238. Case 90‏‎ (2 revisions)
  239. Minor salivary gland biopsy‏‎ (2 revisions)
  240. Case 110‏‎ (2 revisions)
  241. World wide web‏‎ (2 revisions)
  242. Next generation sequencing‏‎ (2 revisions)
  243. Lymphangitic carcinomatosis‏‎ (2 revisions)
  244. Bronchiectasis‏‎ (2 revisions)
  245. Flat epithelial atypia‏‎ (2 revisions)
  246. VANTAGE‏‎ (2 revisions)
  247. Eye papilloma‏‎ (2 revisions)
  248. MST‏‎ (2 revisions)
  249. Nodular lymphoid hyperplasia‏‎ (2 revisions)
  250. Leiomyoma of the urinary bladder‏‎ (2 revisions)

View (previous 250 | next 250) (20 | 50 | 100 | 250 | 500)